These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 18524979)

  • 41. Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation.
    Leclerc P; Idborg H; Spahiu L; Larsson C; Nekhotiaeva N; Wannberg J; Stenberg P; Korotkova M; Jakobsson PJ
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():26-34. PubMed ID: 24045148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acetaminophen reduces lipopolysaccharide-induced fever by inhibiting cyclooxygenase-2.
    Engström Ruud L; Wilhelms DB; Eskilsson A; Vasilache AM; Elander L; Engblom D; Blomqvist A
    Neuropharmacology; 2013 Aug; 71():124-9. PubMed ID: 23545161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis.
    Sasaki Y; Kamei D; Ishikawa Y; Ishii T; Uematsu S; Akira S; Murakami M; Hara S
    Oncogene; 2012 Jun; 31(24):2943-52. PubMed ID: 21986945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fragment-based discovery of novel and selective mPGES-1 inhibitors Part 1: identification of sulfonamido-1,2,3-triazole-4,5-dicarboxylic acid.
    Lee K; Pham VC; Choi MJ; Kim KJ; Lee KT; Han SG; Yu YG; Lee JY
    Bioorg Med Chem Lett; 2013 Jan; 23(1):75-80. PubMed ID: 23218602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis.
    Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
    FASEB J; 2006 Nov; 20(13):2387-9. PubMed ID: 17023389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E
    Muthukaman N; Tambe M; Shaikh M; Pisal D; Deshmukh S; Tondlekar S; Sarode N; Narayana L; Gajera JM; Kattige VG; Honnegowda S; Karande V; Kulkarni A; Behera D; Jadhav SB; Gudi GS; Khairatkar-Joshi N; Gharat LA
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2594-2601. PubMed ID: 28400234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Membrane prostaglandin E synthase-1: a novel therapeutic target.
    Samuelsson B; Morgenstern R; Jakobsson PJ
    Pharmacol Rev; 2007 Sep; 59(3):207-24. PubMed ID: 17878511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostaglandin E2 produced by microsomal prostaglandin E synthase-1 regulates the onset and the maintenance of wakefulness.
    Takemiya T
    Neurochem Int; 2011 Nov; 59(6):922-4. PubMed ID: 21784115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
    Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
    Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toward the discovery of new agents able to inhibit the expression of microsomal prostaglandin E synthase-1 enzyme as promising tools in drug development.
    De Simone R; Andrés RM; Aquino M; Bruno I; Guerrero MD; Terencio MC; Paya M; Riccio R
    Chem Biol Drug Des; 2010 Jul; 76(1):17-24. PubMed ID: 20492447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression.
    Guerrero MD; Aquino M; Bruno I; Riccio R; Terencio MC; Payá M
    Eur J Pharmacol; 2009 Oct; 620(1-3):112-9. PubMed ID: 19686718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages.
    Lazarus M; Kubata BK; Eguchi N; Fujitani Y; Urade Y; Hayaishi O
    Arch Biochem Biophys; 2002 Jan; 397(2):336-41. PubMed ID: 11795891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 as functional targets of the anti-inflammatory and anti-carcinogenic garcinol.
    Koeberle A; Northoff H; Werz O
    Biochem Pharmacol; 2009 May; 77(9):1513-21. PubMed ID: 19426689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery and biological evaluation of a novel class of dual microsomal prostaglandin E2 synthase-1/5-lipoxygenase inhibitors based on 2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid.
    Hieke M; Greiner C; Dittrich M; Reisen F; Schneider G; Schubert-Zsilavecz M; Werz O
    J Med Chem; 2011 Jul; 54(13):4490-507. PubMed ID: 21591611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis.
    Engblom D; Saha S; Engström L; Westman M; Audoly LP; Jakobsson PJ; Blomqvist A
    Nat Neurosci; 2003 Nov; 6(11):1137-8. PubMed ID: 14566340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents.
    De Simone R; Chini MG; Bruno I; Riccio R; Mueller D; Werz O; Bifulco G
    J Med Chem; 2011 Mar; 54(6):1565-75. PubMed ID: 21323313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E(2) synthase-1.
    Koeberle A; Bauer J; Verhoff M; Hoffmann M; Northoff H; Werz O
    Biochem Biophys Res Commun; 2009 Oct; 388(2):350-4. PubMed ID: 19665000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is mPGES-1 a promising target for pain therapy?
    Scholich K; Geisslinger G
    Trends Pharmacol Sci; 2006 Aug; 27(8):399-401. PubMed ID: 16815559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2.
    Esser R; Berry C; Du Z; Dawson J; Fox A; Fujimoto RA; Haston W; Kimble EF; Koehler J; Peppard J; Quadros E; Quintavalla J; Toscano K; Urban L; van Duzer J; Zhang X; Zhou S; Marshall PJ
    Br J Pharmacol; 2005 Feb; 144(4):538-50. PubMed ID: 15655513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.